News: Cancer News

Next Page »

‘Docking stations’ on chromosomes new anti-cancer target

Thursday, March 26th, 2015

Vanderbilt University researchers have discovered a cleft in a chromosome-binding protein that may hold the key to stopping most cancers in their tracks. The protein, WDR5, is a “docking station” for a family of transcription factors called MYC that is overexpressed in the majority of malignancies and which contributes to an estimated 100,000 cancer-related deaths […]

VICC’s Johnson to study cancer survivorship with immune inhibitor drugs

Thursday, March 19th, 2015

Douglas Johnson, M.D., assistant professor of Medicine, has been named a recipient of the National Comprehensive Cancer Network  (NCCN) Foundation Young Investigator Awards. The two-year grant will provide $150,000 in funding for his research on survivorship among cancer patients who receive drugs called immune checkpoint inhibitors. The formal announcement of the grant awardees was made […]

Team blends high-end imaging techniques

Monday, March 16th, 2015

Vanderbilt University researchers have achieved the first “image fusion” of mass spectrometry and microscopy — a technical tour de force that could, among other things, dramatically improve the diagnosis and treatment of cancer. Microscopy can yield high-resolution images of tissues, but “it really doesn’t give you molecular information,” said Richard Caprioli, Ph.D., senior author of […]

Barocas named to Commission on Cancer

Thursday, March 12th, 2015

Daniel Barocas, M.D., MPH, assistant professor of Urologic Surgery at Vanderbilt University Medical Center, was recently named a representative on the Commission on Cancer. The program helps to raise the quality of care at hospitals across the country through developing standards for cancer care and uses those standards to accredit hospitals. Barocas will represent the […]

Mutations may predict melanoma response to immunotherapies

Thursday, March 12th, 2015

Melanoma patients whose tumors test positive for mutations in the NRAS gene were more likely to benefit from new immunotherapy drugs, according to a new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators. Douglas Johnson, M.D., assistant professor of Medicine, and Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology, are co-first authors […]

‘Cancer: The Emperor of All Maladies’

Wednesday, March 11th, 2015

The Vanderbilt-Ingram Cancer Center, in collaboration with Nashville Public Television, American Cancer Society, and Gilda’s Club, will host a free preview of “Cancer: The Emperor of All Maladies,” panel discussion and moderated Q&A on Wednesday, March 25 at the Vanderbilt University Student Life Center.

Zanic’s journey to lab followed winding path

Monday, March 9th, 2015

It’s roughly 5,000 miles from Croatia to Tennessee as the crow flies. For Marija Zanic, Ph.D., who joined Vanderbilt University’s Department of Cell and Developmental Biology as an assistant professor last August, the journey from her home country took a more circuitous route — from cell biology to theoretical physics and back again. Zanic’s dissertation […]

Moses, Shyr named to IOM cancer therapies panel

Monday, March 9th, 2015

Two Vanderbilt-Ingram Cancer Center (VICC) leaders have been named to a panel of the Institute of Medicine (IOM) to help shape national policies on the use of biomarkers for targeted cancer therapies. Harold L. (Hal) Moses, M.D., Ingram Professor of Cancer Research and director emeritus of VICC, will chair the IOM’s ad hoc committee, Policy […]

Grant boosts head and neck lymphedema research

Monday, March 9th, 2015

Vanderbilt University School of Nursing (VUSN) has been awarded a four-year, $2.4 million grant from the National Institutes of Health/National Institute of Dental and Craniofacial Research to establish a valid, clinically useful measurement battery for head and neck lymphedema and fibrosis (LEF). Principal investigator Jie Deng, Ph.D., R.N., developed the proposal because she commonly sees […]

MDS patient and family forum March 14

Monday, March 2nd, 2015

The Myelodysplastic Syndrome Foundation, Inc., is sponsoring a patient and caregiver forum on March 14, 2015 at the Marriott Nashville at Vanderbilt. The forum will feature a presentation and Q&A session with Vanderbilt-Ingram Cancer Center’s Michael Savona, M.D., about new therapies and treatment options for MDS. The conference runs from 9:30 a.m. to 2:00 p.m. and will also […]